Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

CODX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

CODX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Co-Diagnostics, Inc.(CODX US)

$0.26-0.014.12%Ext:$0.25-0.001.64%(After Hours · 00:30:12 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

Co-Diagnostics, Inc.(CODX US)

$0.26-0.014.12%Ext:$0.25-0.001.64%(After Hours · 00:30:12 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

SEC Filings

Financials(39)

Expand
  • 10-QQ3ended 30 Sept 202610 Nov
  • 10-QQ2ended 30 Jun 202613 Aug
  • 10-QQ1ended 31 Mar 202614 May
  • 10-KFY 2025ended 31 Dec 202531 Mar
  • 10-QQ3ended 30 Sept 202513 Nov 2025
  • 10-QQ2ended 30 Jun 202514 Aug 2025
  • 10-QQ1ended 31 Mar 20258 May 2025
  • 10-KFY 2024ended 31 Dec 202427 Mar 2025
  • 10-QQ3ended 30 Sept 20247 Nov 2024
  • 10-QQ2ended 30 Jun 20248 Aug 2024
  • 10-QQ1ended 31 Mar 20249 May 2024
  • 10-KFY 2023ended 31 Dec 202314 Mar 2024
  • 10-QQ3ended 30 Sept 20239 Nov 2023
  • 10-QQ2ended 30 Jun 202310 Aug 2023
  • 10-QQ1ended 31 Mar 202311 May 2023

Events(87)

Expand
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers05:00PM
  • 8-KResults of Operations and Financial Condition10 Nov
  • 8-KSubmission of Matters to a Vote of Security Holders15 Oct
  • 8-K/AEntry into a Material Definitive Agreement15 Oct
  • 8-KEntry into a Material Definitive Agreement13 Oct
  • 8-KSubmission of Matters to a Vote of Security Holders2 Oct
  • 8-KSubmission of Matters to a Vote of Security Holders25 Sep
  • 8-KRegulation FD Disclosure16 Sep
  • 8-KOther Events16 Sep
  • 8-KOther Events15 Sep
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers4 Sep
  • 8-KSubmission of Matters to a Vote of Security Holders4 Sep
  • 8-KResults of Operations and Financial Condition13 Aug
  • 8-KEntry into a Material Definitive Agreement31 Jul
  • 8-KEntry into a Material Definitive Agreement27 Jul

Insider Ownership(159)

Expand
  • Form 3Bohrer Daniel14 Sep
  • Form 4Egan Dwight H27 May
  • Form 4Brown Brian Lee27 May
  • Form 4Abbott Richard David27 May
  • Form 4Murphy Edward L.27 May
  • Form 4SERBIN RICHARD S27 May
  • Form 4Durenard Eugene27 May
  • Form 4NELSON JAMES B27 May
  • Form 4Murphy Edward L.24 Nov 2025
  • Form 4Brown Brian Lee24 Nov 2025
  • Form 4Abbott Richard David24 Nov 2025
  • Form 4Egan Dwight H24 Nov 2025
  • Form 4SERBIN RICHARD S24 Nov 2025
  • Form 4Durenard Eugene24 Nov 2025
  • Form 4NELSON JAMES B24 Nov 2025

Beneficial Ownership(25)

Expand
  • SC 13GCo-Diagnostics, Inc.14 Aug
  • SC 13G/ACo-Diagnostics, Inc.10 Aug
  • SC 13GCo-Diagnostics, Inc.3 Jun
  • SC 13G/ACo-Diagnostics, Inc.11 Feb
  • SC 13GCo-Diagnostics, Inc.13 Nov 2025
  • SC 13G/ACo-Diagnostics, Inc.30 Oct 2025
  • SC 13G/ACo-Diagnostics, Inc.30 Oct 2025
  • SC 13G/ACo-Diagnostics, Inc.30 Oct 2025
  • SC 13G/ACo-Diagnostics, Inc.19 Sep 2025
  • SC 13GCo-Diagnostics, Inc.18 Sep 2025
  • SC 13G/ACo-Diagnostics, Inc.13 Feb 2024
  • SC 13G/ACo-Diagnostics, Inc.9 Feb 2023
  • SC 13G/ACo-Diagnostics, Inc.9 Feb 2022
  • SC 13G/ACo-Diagnostics, Inc.12 Jul 2021
  • SC 13GCo-Diagnostics, Inc.10 Feb 2021

Proxies(18)

Expand
  • DEF 14ADefinitive proxy statement26 Oct
  • PRE 14APreliminary proxy statement19 Oct
  • PRE 14APreliminary proxy statement21 Sep
  • DEFA14ADefinitive additional materials4 Sep
  • DEF 14ADefinitive proxy statement21 Jul
  • PRE 14APreliminary proxy statement9 Jul
  • DEF 14ADefinitive proxy statement10 Nov 2025
  • PRE 14APreliminary proxy statement31 Oct 2025
  • DEF 14ADefinitive proxy statement14 Apr 2025
  • DEF 14ADefinitive proxy statement16 Jul 2024
  • DEF 14ADefinitive proxy statement20 Jul 2023
  • DEF 14ADefinitive proxy statement20 Jul 2022
  • DEF 14ADefinitive proxy statement22 Jun 2021
  • DEFA14ADefinitive additional materials3 Nov 2020
  • DEF 14ADefinitive proxy statement3 Nov 2020

Registrations(35)

Expand
  • S-3Registration statement (primary offering)4 Nov
  • S-3Registration statement (primary offering)24 Aug
  • 424B5Prospectus filing (Rule 424(b)(5))27 Jul
  • S-3Registration statement (primary offering)28 May
  • DRSDraft registration statement22 May
  • S-3Registration statement (primary offering)12 May
  • DRSDraft registration statement10 Apr
  • S-8Registration statement (employee benefit plan)21 Jan
  • 424B5Prospectus filing (Rule 424(b)(5))19 Dec 2025
  • 424B5Prospectus filing (Rule 424(b)(5))28 Oct 2025
  • 424B5Prospectus filing (Rule 424(b)(5))20 Oct 2025
  • 424B5Prospectus filing (Rule 424(b)(5))18 Sep 2025
  • 424B5Prospectus filing (Rule 424(b)(5))16 Sep 2025
  • 424B5Prospectus filing (Rule 424(b)(5))18 Oct 2024
  • S-3Registration statement (primary offering)16 Mar 2023

Filing Review Correspondence(11)

Expand
  • CORRESPFiling review correspondence28 May
  • CORRESPFiling review correspondence13 May
  • CORRESPFiling review correspondence4 Apr 2023
  • CORRESPFiling review correspondence2 Nov 2020
  • CORRESPFiling review correspondence5 Sep 2018
  • CORRESPFiling review correspondence12 Jul 2017
  • CORRESPFiling review correspondence11 Jul 2017
  • CORRESPFiling review correspondence28 Jun 2017
  • CORRESPFiling review correspondence9 Jun 2017
  • CORRESPFiling review correspondence24 May 2017
  • DRSLTRFiling review correspondence (DRSLTR)30 Mar 2017

SEC Orders And Notices(7)

Expand
  • EFFECTNotice of effectiveness2 Sep
  • EFFECTNotice of effectiveness1 Jun
  • EFFECTNotice of effectiveness18 May
  • EFFECTNotice of effectiveness6 Apr 2023
  • EFFECTNotice of effectiveness5 Nov 2020
  • EFFECTNotice of effectiveness7 Sep 2018
  • EFFECTNotice of effectiveness11 Jul 2017

Exempt Offerings(2)

Expand
  • D06b14 Jan 2022
  • D06b29 Dec 2016

Other(1)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT11 Jul 2017

Financials(39)

Expand
  • 10-QQ3ended 30 Sept 202610 Nov
  • 10-QQ2ended 30 Jun 202613 Aug
  • 10-QQ1ended 31 Mar 202614 May
  • 10-KFY 2025ended 31 Dec 202531 Mar
  • 10-QQ3ended 30 Sept 202513 Nov 2025
  • 10-QQ2ended 30 Jun 202514 Aug 2025
  • 10-QQ1ended 31 Mar 20258 May 2025
  • 10-KFY 2024ended 31 Dec 202427 Mar 2025
  • 10-QQ3ended 30 Sept 20247 Nov 2024
  • 10-QQ2ended 30 Jun 20248 Aug 2024
  • 10-QQ1ended 31 Mar 20249 May 2024
  • 10-KFY 2023ended 31 Dec 202314 Mar 2024
  • 10-QQ3ended 30 Sept 20239 Nov 2023
  • 10-QQ2ended 30 Jun 202310 Aug 2023
  • 10-QQ1ended 31 Mar 202311 May 2023

Events(87)

Expand
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers05:00PM
  • 8-KResults of Operations and Financial Condition10 Nov
  • 8-KSubmission of Matters to a Vote of Security Holders15 Oct
  • 8-K/AEntry into a Material Definitive Agreement15 Oct
  • 8-KEntry into a Material Definitive Agreement13 Oct
  • 8-KSubmission of Matters to a Vote of Security Holders2 Oct
  • 8-KSubmission of Matters to a Vote of Security Holders25 Sep
  • 8-KRegulation FD Disclosure16 Sep
  • 8-KOther Events16 Sep
  • 8-KOther Events15 Sep
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers4 Sep
  • 8-KSubmission of Matters to a Vote of Security Holders4 Sep
  • 8-KResults of Operations and Financial Condition13 Aug
  • 8-KEntry into a Material Definitive Agreement31 Jul
  • 8-KEntry into a Material Definitive Agreement27 Jul

Insider Ownership(159)

Expand
  • Form 3Bohrer Daniel14 Sep
  • Form 4Egan Dwight H27 May
  • Form 4Brown Brian Lee27 May
  • Form 4Abbott Richard David27 May
  • Form 4Murphy Edward L.27 May
  • Form 4SERBIN RICHARD S27 May
  • Form 4Durenard Eugene27 May
  • Form 4NELSON JAMES B27 May
  • Form 4Murphy Edward L.24 Nov 2025
  • Form 4Brown Brian Lee24 Nov 2025
  • Form 4Abbott Richard David24 Nov 2025
  • Form 4Egan Dwight H24 Nov 2025
  • Form 4SERBIN RICHARD S24 Nov 2025
  • Form 4Durenard Eugene24 Nov 2025
  • Form 4NELSON JAMES B24 Nov 2025

Beneficial Ownership(25)

Expand
  • SC 13GCo-Diagnostics, Inc.14 Aug
  • SC 13G/ACo-Diagnostics, Inc.10 Aug
  • SC 13GCo-Diagnostics, Inc.3 Jun
  • SC 13G/ACo-Diagnostics, Inc.11 Feb
  • SC 13GCo-Diagnostics, Inc.13 Nov 2025
  • SC 13G/ACo-Diagnostics, Inc.30 Oct 2025
  • SC 13G/ACo-Diagnostics, Inc.30 Oct 2025
  • SC 13G/ACo-Diagnostics, Inc.30 Oct 2025
  • SC 13G/ACo-Diagnostics, Inc.19 Sep 2025
  • SC 13GCo-Diagnostics, Inc.18 Sep 2025
  • SC 13G/ACo-Diagnostics, Inc.13 Feb 2024
  • SC 13G/ACo-Diagnostics, Inc.9 Feb 2023
  • SC 13G/ACo-Diagnostics, Inc.9 Feb 2022
  • SC 13G/ACo-Diagnostics, Inc.12 Jul 2021
  • SC 13GCo-Diagnostics, Inc.10 Feb 2021

Proxies(18)

Expand
  • DEF 14ADefinitive proxy statement26 Oct
  • PRE 14APreliminary proxy statement19 Oct
  • PRE 14APreliminary proxy statement21 Sep
  • DEFA14ADefinitive additional materials4 Sep
  • DEF 14ADefinitive proxy statement21 Jul
  • PRE 14APreliminary proxy statement9 Jul
  • DEF 14ADefinitive proxy statement10 Nov 2025
  • PRE 14APreliminary proxy statement31 Oct 2025
  • DEF 14ADefinitive proxy statement14 Apr 2025
  • DEF 14ADefinitive proxy statement16 Jul 2024
  • DEF 14ADefinitive proxy statement20 Jul 2023
  • DEF 14ADefinitive proxy statement20 Jul 2022
  • DEF 14ADefinitive proxy statement22 Jun 2021
  • DEFA14ADefinitive additional materials3 Nov 2020
  • DEF 14ADefinitive proxy statement3 Nov 2020

Registrations(35)

Expand
  • S-3Registration statement (primary offering)4 Nov
  • S-3Registration statement (primary offering)24 Aug
  • 424B5Prospectus filing (Rule 424(b)(5))27 Jul
  • S-3Registration statement (primary offering)28 May
  • DRSDraft registration statement22 May
  • S-3Registration statement (primary offering)12 May
  • DRSDraft registration statement10 Apr
  • S-8Registration statement (employee benefit plan)21 Jan
  • 424B5Prospectus filing (Rule 424(b)(5))19 Dec 2025
  • 424B5Prospectus filing (Rule 424(b)(5))28 Oct 2025
  • 424B5Prospectus filing (Rule 424(b)(5))20 Oct 2025
  • 424B5Prospectus filing (Rule 424(b)(5))18 Sep 2025
  • 424B5Prospectus filing (Rule 424(b)(5))16 Sep 2025
  • 424B5Prospectus filing (Rule 424(b)(5))18 Oct 2024
  • S-3Registration statement (primary offering)16 Mar 2023

Filing Review Correspondence(11)

Expand
  • CORRESPFiling review correspondence28 May
  • CORRESPFiling review correspondence13 May
  • CORRESPFiling review correspondence4 Apr 2023
  • CORRESPFiling review correspondence2 Nov 2020
  • CORRESPFiling review correspondence5 Sep 2018
  • CORRESPFiling review correspondence12 Jul 2017
  • CORRESPFiling review correspondence11 Jul 2017
  • CORRESPFiling review correspondence28 Jun 2017
  • CORRESPFiling review correspondence9 Jun 2017
  • CORRESPFiling review correspondence24 May 2017
  • DRSLTRFiling review correspondence (DRSLTR)30 Mar 2017

SEC Orders And Notices(7)

Expand
  • EFFECTNotice of effectiveness2 Sep
  • EFFECTNotice of effectiveness1 Jun
  • EFFECTNotice of effectiveness18 May
  • EFFECTNotice of effectiveness6 Apr 2023
  • EFFECTNotice of effectiveness5 Nov 2020
  • EFFECTNotice of effectiveness7 Sep 2018
  • EFFECTNotice of effectiveness11 Jul 2017

Exempt Offerings(2)

Expand
  • D06b14 Jan 2022
  • D06b29 Dec 2016

Other(1)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT11 Jul 2017